Suppr超能文献

一种在经导管主动脉瓣植入术中避免临时起搏导线穿破右心室的新方法。

A novel technique to avoid perforation of the right ventricle by the temporary pacing lead during transcatheter aortic valve implantation.

机构信息

Department of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Teikyo University School of Medicine, Tokyo, Japan.

出版信息

Cardiovasc Interv Ther. 2021 Jul;36(3):347-354. doi: 10.1007/s12928-020-00676-0. Epub 2020 May 30.

Abstract

Cardiac tamponade is a life-threatening complication during transcatheter aortic valve implantation (TAVI), often caused by perforation of the right ventricle (RV) by the temporary pacemaker used for rapid pacing during valve deployment. We aimed to assess the feasibility of performing rapid pacing while maintaining inflation of the pacing lead balloon in the RV during TAVI. Among 749 consecutive patients who underwent TAVI with SAPIEN XT valves between October 2013 and July 2015, 726 treated using rapid pacing with a transvenous balloon-tip lead were enrolled in our study, and were stratified into three groups according to the extent of balloon inflation in the RV as follows: full inflation (n = 100), partial inflation (n = 196), and deflation (n = 430). We compared the following clinical outcomes: pacing lead-related RV perforation, rapid pacing failure, valve malpositioning due to rapid pacing failure, device success, and 30-day mortality. Pacing lead-related RV perforation occurred only in patients in the deflation group (6 cases, 1.4%), but the differences among the groups were not statistically significant (p = 0.13). Rapid pacing failure, but no valve malpositioning, occurred most frequently in patients in the full inflation group (4.0% vs. 0.5% in the other groups, p = 0.004). The rate of device success (> 94%) and the 30-day mortality (2.0%) were similar among the three groups. Partial inflation of the balloon of the pacing lead may reduce the risk of RV perforation without increasing the risk of pacing failure or valve malpositioning.

摘要

心脏压塞是经导管主动脉瓣植入术(TAVI)期间危及生命的并发症,通常由在瓣膜部署期间用于快速起搏的临时起搏电极穿孔引起。我们旨在评估在 TAVI 期间保持起搏导联球囊充气的同时进行快速起搏的可行性。在 2013 年 10 月至 2015 年 7 月期间接受 SAPIEN XT 瓣膜 TAVI 的 749 例连续患者中,726 例采用经静脉球囊尖端导联进行快速起搏,根据 RV 中球囊充气的程度分为三组:完全充气(n=100)、部分充气(n=196)和放气(n=430)。我们比较了以下临床结局:起搏导联相关 RV 穿孔、快速起搏失败、因快速起搏失败导致瓣膜错位、器械成功和 30 天死亡率。仅在放气组的患者中发生起搏导联相关 RV 穿孔(6 例,1.4%),但组间差异无统计学意义(p=0.13)。快速起搏失败(但无瓣膜错位)最常发生在完全充气组的患者中(4.0%比其他组的 0.5%,p=0.004)。三组的器械成功率(>94%)和 30 天死亡率(2.0%)相似。起搏导联球囊部分充气可能降低 RV 穿孔的风险,而不会增加起搏失败或瓣膜错位的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验